These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 33522631)

  • 1. Role for digoxin in patients hospitalized with COVID-19 and atrial arrhythmias.
    Peltzer B; Lerman BB; Goyal P; Cheung JW
    J Cardiovasc Electrophysiol; 2021 Mar; 32(3):880-881. PubMed ID: 33522631
    [No Abstract]   [Full Text] [Related]  

  • 2. Atrial fibrillation and flutter in patients hospitalized for COVID-19: The challenging role of digoxin.
    Siniorakis E; Arvanitakis S; Katsianis A; Elkouris M
    J Cardiovasc Electrophysiol; 2021 Mar; 32(3):878-879. PubMed ID: 33522637
    [No Abstract]   [Full Text] [Related]  

  • 3. Atrial Arrhythmias in a Patient Presenting With Coronavirus Disease-2019 (COVID-19) Infection.
    Seecheran R; Narayansingh R; Giddings S; Rampaul M; Furlonge K; Abdool K; Bhagwandass N; Seecheran NA
    J Investig Med High Impact Case Rep; 2020; 8():2324709620925571. PubMed ID: 32370558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyperthyroid-induced atrial flutter-fibrillation with profound sinoatrial nodal pauses due to small doses of digoxin, verapamil, and propranolol.
    Talley JD; Wathen MS; Hurst JW
    Clin Cardiol; 1989 Jan; 12(1):45-7. PubMed ID: 2912608
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Digoxin for atrial fibrillation and atrial flutter: A systematic review with meta-analysis and trial sequential analysis of randomised clinical trials.
    Sethi NJ; Nielsen EE; Safi S; Feinberg J; Gluud C; Jakobsen JC
    PLoS One; 2018; 13(3):e0193924. PubMed ID: 29518134
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Two unusual phenomena observed after brief treatment with moderate doses of digoxin: escape-capture bigeminy; vertigo due to auricular and ventricular arrest in the course of paroxysmal auricular fibrillation].
    Geraci E; Serio G; Cospite M
    Boll Soc Ital Cardiol; 1966; 11(4):1054-65. PubMed ID: 5992020
    [No Abstract]   [Full Text] [Related]  

  • 7. Impact of the coronavirus disease 2019 pandemic on atrial fibrillation and atrial flutter ablation rates. The analysis of nearly 5 million Polish population.
    Myrda K; Błachut A; Buchta P; Skrzypek M; Wnuk-Wojnar AM; Hoffmann A; Nowak S; Kowalski O; Pruszkowska P; Sokal A; Wita K; Mizia-Stec K; Gąsior M; Kalarus Z
    Kardiol Pol; 2021; 79(6):687-689. PubMed ID: 33926171
    [No Abstract]   [Full Text] [Related]  

  • 8. [Treatment with maintenance dose of digoxin; an analysis of 102 cases].
    Yang ZB; Li S
    Zhonghua Xin Xue Guan Bing Za Zhi; 1980 Mar; 8(1):20-2. PubMed ID: 7449612
    [No Abstract]   [Full Text] [Related]  

  • 9. Left Atrial Function in Patients with Coronavirus Disease 2019 and Its Association with Incident Atrial Fibrillation/Flutter.
    Goerlich E; Minhas A; Gilotra N; Barth AS; Mukherjee M; Parziale A; Wu KC; Hays AG
    J Am Soc Echocardiogr; 2021 Oct; 34(10):1106-1109. PubMed ID: 34082022
    [No Abstract]   [Full Text] [Related]  

  • 10. Atrial flutter or atrial fibrillation?
    Hancock EW
    Hosp Pract (1995); 1995 Aug; 30(8):17-8. PubMed ID: 7635905
    [No Abstract]   [Full Text] [Related]  

  • 11. Atrial flutter due to digitalis toxicity.
    Parameswaran R
    Cardiologia (Basel); 1968; 53(1):57-63. PubMed ID: 5733884
    [No Abstract]   [Full Text] [Related]  

  • 12. Clinical characteristics of patients with atrial fibrillation or atrial flutter hospitalized during the COVID-19 pandemic: a population analysis of nearly 5 million people.
    Myrda K; Błachut A; Buchta P; Skrzypek M; Wnuk-Wojnar AM; Hoffmann A; Nowak S; Kowalski O; Pruszkowska P; Sokal A; Wita K; Mizia-Stec K; Gąsior M; Kalarus Z
    Pol Arch Intern Med; 2021 Jun; 131(6):574-577. PubMed ID: 33973747
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical decision analysis modeling: short-term control of ventricular response rate in atrial fibrillation or atrial flutter-digoxin versus diltiazem.
    Gonzalez ER; Ornato JP; Lawson CL
    Pharmacotherapy; 1994; 14(4):446-51. PubMed ID: 7937281
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diaphoresis with digoxin.
    Lofgren RP
    N Engl J Med; 1980 Apr; 302(16):919. PubMed ID: 7360179
    [No Abstract]   [Full Text] [Related]  

  • 15. Management of atrial fibrillation and flutter. A reappraisal of digitalis therapy.
    Simpson RJ; Foster JR; Woelfel AK; Gettes LS
    Postgrad Med; 1986 Jun; 79(8):241-53. PubMed ID: 3520525
    [No Abstract]   [Full Text] [Related]  

  • 16. COVID-19-associated myocarditis presenting as new-onset heart failure and atrial fibrillation.
    Gaine S; Devitt P; Coughlan JJ; Pearson I
    BMJ Case Rep; 2021 Jul; 14(7):. PubMed ID: 34253533
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A prospective, randomized controlled trial comparing the efficacy and safety of sotalol, amiodarone, and digoxin for the reversion of new-onset atrial fibrillation.
    Joseph AP; Ward MR
    Ann Emerg Med; 2000 Jul; 36(1):1-9. PubMed ID: 10874228
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pharmacologic restoration of sinus rhythm in atrial flutter and fibrillation].
    Vainer J; Smíd J; Cepeláková H; Hapala J; Topinka I; Topolcan O
    Vnitr Lek; 1989 Feb; 35(2):145-50. PubMed ID: 2711622
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectiveness and costs of digoxin treatment for atrial fibrillation and flutter.
    Roberts SA; Diaz C; Nolan PE; Salerno DM; Stapczynski JS; Zbrozek AS; Ritz EG; Bauman JL; Vlasses PH
    Am J Cardiol; 1993 Sep; 72(7):567-73. PubMed ID: 8362772
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The relation of quinidine-induced elevation of serum digoxin concentration to the conversion of atrial fibrillation-flutter: a pilot study.
    Shah S; Friedman HS
    Cardiovasc Drugs Ther; 1989 Dec; 3(6):929-30. PubMed ID: 2487553
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.